Xeris Pharmaceuticals Inc (XERS) — Cash Flow Quality Index
Xeris Pharmaceuticals Inc (XERS) has a Cash Flow Quality Index of 1.81x as of December 2025. Operating cash flow of $20.04 Million exceeds net income of $11.08 Million, indicating high earnings quality where cash backs reported profits. Explore Xeris Pharmaceuticals Inc (XERS) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xeris Pharmaceuticals Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Xeris Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Xeris Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Xeris Pharmaceuticals Inc (2025–2025)
Year-by-year earnings quality comparison for Xeris Pharmaceuticals Inc. For live market cap and the full company financial profile, see Xeris Pharmaceuticals Inc stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 51.67x | $28.63 Million | $554.00K | — |